Back
Amgen 10K Form
Sell
50
AMGN
Amgen
Last Price:
286.33
Seasonality Move:
2.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-14 | 10K | AMGN/Amgen Annual |
2023-10-31 | 10Q | AMGN/Amgen Quarterly |
2023-08-04 | 10Q | AMGN/Amgen Quarterly |
2023-04-28 | 10Q | AMGN/Amgen Quarterly |
2023-02-09 | 10K | AMGN/Amgen Annual |
2022-11-04 | 10Q | AMGN/Amgen Quarterly |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
Annual Sales: | $28.19B |
---|---|
Cash Flow: | $289M |
Price / Cash Flow: | 20.92 |
Annual Sales: | $11.64 |
Price / Book: | 24.62 |
Profitability
EPS (TTM): | 12.49000 |
---|---|
Net Income (TTM): | $6.72B |
Gross Margin: | $19.74B |
Return on Equity: | 113.17% |
Return on Assets: | 7.78% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 40 years for AMGN is 70.02%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 21.92% of Gross Profit Margin.
- The Research & Development expenses have been 16.97% of Revenue.
- The Interest Expense is 42.80% of Operating Income.
- The Net Earning history of AMGN is 23.83% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 26 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
Current Symbol: | AMGN |
CUSIP: | 031162 |
Website: | amgen.com |
Debt
Debt-to-Equity Ratio: | 10.37 |
---|---|
Current Ratio: | 1.65 |
Quick Ratio: | 1.03 |
Price-to-Earnings
Trailing P/E Ratio: | 22.92 |
---|---|
Forward P/E Ratio: | 13.56 |